JCJohn Civale

John Civale

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


John Civale has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Algorithms for Mapping Elastic Modulus (aMEM) Challenge

    by J. Civale, T. Meyer, J. C. Bamber, M. Palmeri, M. W. Urban, H. Tzschatzsch, E. J. Harris

  • Implementation and repeatability of preclinical continuous vibration shear wave elastography

    by John Civale, Vaidesh Parasaram, Jeffrey C Bamber, Emma J Harris

    Objective . The biomechanical properties of tissue are of interest in preclinical cancer research where their changes can be related to treatment response. Preclinical shear wave elastography (SWE) may be used to measure the viscoelastic properties of tumours although their small size presents challenges. Here we study the repeatability of 3D shear wave speed (SWS) measurements using continuous harmonic vibrations under different conditions in a preclinical in-vivo tumour model. Approach . Subcutaneous tumours (MDA-MB-231) grown on the flank of athymic nude mice ( n = 4) were imaged using a system comprising a research ultrasound scanner and a mechanically translated 18 MHz linear imaging probe. Shear waves were induced in the tumours by external contactors driven at three different vibration frequencies (500, 700 and 1000 Hz), in two orientations (top and side), sedated in separate sessions using injectables or breathable anaesthesia. Measurements were repeated over three consecutive days. 3D tumour volume outlines were used to determine the spatial transformation required to register sets of 3D SWS data, allowing measurement of repeatability of the 3D pattern of SWS using normalised cross correlation. Main results . Analysis of variance of mean SWS measurements (2–5 m s −1 ) revealed significant differences between the tumours ( p < 0.001), and vibration frequencies ( p < 0.001). Mean SWS was not significantly affected by the choice of anaesthetic or tumour orientation. Intratumoural SWS spatial distributions showed improved day-to-day repeatability when obtained from the same tumour (+76% increase in normalised cross correlation compared to different tumours), the same orientation (+39% compared to different orientations), and when using a side orientation at 500 Hz (+18% compared to top orientations). Breathing motion with gaseous anaesthesia was found to be slower (∼1.5 s vs ∼0.5 s period) but with greater amplitude (Significance . SWE with continuous vibration is a repeatable and feasible technique for in-vivo preclinical use.

  • Radiotherapeutic enhancement using ultrasound-stimulated microbubbles: a critical review

    by Hannah Bargh-Dawson, Carol Box, John Civale, Graeme M. Birdsey, Jeffrey C. Bamber, Emma Harris

    Ultrasound stimulated microbubbles (USMB) are proposed as radioenhancing agents. Acting mechanically, they are attractive because their effects can be localized to the tumor, limiting the potential for normal tissue toxicity. Extensive preclinical research in models of human cancers has demonstrated increased tumor control when USMB are combined with radiotherapy compared with radiation alone, which has led to recent Phase I trials. The leading theory on the radioenhancement mechanism of action (MOA) is that USMB act as vascular disrupting agents, but others are proposed. Current literature was reviewed with a focus on the role of the tumor vasculature on radiotherapy response, the bioeffects of USMB on the vasculature, and studies of USMB as radioenhancers. Additionally, the possible interplay between USMB as vascular modulators, and radiation-induced anti-tumor immunity, is explored. Whilst most preclinical evidence compellingly describes the radioenhancement effect, only one study considers the immune cell infiltration post USMB plus radiotherapy, with non-significant findings. Clinical studies demonstrate the safety of USMB. As a monotherapy, USMB can alter tumor immune microenvironments and induce a variety of bioeffects on the vasculature, depending on the stimulatory acoustic parameters. Treatment parameters used to study the effects of USMB alone, and with radiotherapy, vary in the literature making direct comparisons difficult. Further work exploring USMB for radioenhancement is warranted. Elucidation of the MOA is required to support clinical translation, particularly with a view to optimize treatment parameters.


  • Open Access

    High frequency ultrasound vibrational shear wave elastography for preclinical research

    by J Civale, V Parasaram, Jc Bamber, Ej Harris

    Preclinical evaluation of novel therapies using models of cancer is an important tool in cancer research, where imaging can provide non-invasive tools to characterise the internal structure and function of tumours. The short propagation paths when imaging tumours and organs in small animals allow the use of high frequencies for both ultrasound and shear waves, providing the opportunity for high-resolution shear wave elastography and hence its use for studying the heterogeneity of tissue elasticity, where heterogeneity may be a predictor of tissue response. Here we demonstrate vibrational shear wave elastography (VSWE) using a mechanical actuator to produce high frequency (up to 1000 Hz) shear waves in preclinical tumours, an alternative to the majority of preclinical ultrasound SWE studies where an acoustic radiation force impulse is required to create a relatively low-frequency broad-band shear-wave pulse. We implement VSWE with a high frequency (17.8 MHz) probe running a focused line-by-line ultrasound imaging sequence which as expected was found to offer improved detection of 1000 Hz shear waves over an ultrafast planar wave imaging sequence in a homogenous tissue-mimicking phantom. We test the VSWE in an ex vivo tumour xenograft, demonstrating the ability to detect shear waves up to 10 mm from the contactor position at 1000 Hz. By reducing the kernel size used for shear wave speed estimation to 1 mm we are able to produce shear wave speed images with spatial resolution of this order. Finally, we present VSWE data from xenograft tumours in vivo , demonstrating the feasibility of the technique in mice under isoflurane sedation. Mean shear wave speeds in the tumours are in good agreements with those reported by previous authors. Characterising the frequency dependence of shear wave speed demonstrates the potential to quantify the viscoelastic properties of tumours in vivo .


  • Open Access

    Preclinical Three-Dimensional Vibrational Shear Wave Elastography for Mapping of Tumour Biomechanical Properties In Vivo

    by Vaideesh Parasaram, John Civale, Jeffrey C. Bamber, Simon P. Robinson, Yann Jamin, Emma Harris

    Preclinical investigation of the biomechanical properties of tissues and their treatment-induced changes are essential to support drug-discovery, clinical translation of biomarkers of treatment response, and studies of mechanobiology. Here we describe the first use of preclinical 3D elastography to map the shear wave speed (cs), which is related to tissue stiffness, in vivo and demonstrate the ability of our novel 3D vibrational shear wave elastography (3D-VSWE) system to detect tumour response to a therapeutic challenge. We investigate the use of one or two vibrational sources at vibrational frequencies of 700, 1000 and 1200 Hz. The within-subject coefficients of variation of our system were found to be excellent for 700 and 1000 Hz and 5.4 and 6.2%, respectively. The relative change in cs measured with our 3D-VSWE upon treatment with an anti-vascular therapy ZD6126 in two tumour xenografts reflected changes in tumour necrosis. U-87 MG drug vs vehicle: Δcs = −24.7 ± 2.5 % vs 7.5 ± 7.1%, (p = 0.002) and MDA-MB-231 drug vs vehicle: Δcs = −12.3 ± 2.7 % vs 4.5 ± 4.7%, (p = 0.02). Our system enables rapid (<5 min were required for a scan length of 15 mm and three vibrational frequencies) 3D mapping of quantitative tumour viscoelastic properties in vivo, allowing exploration of regional heterogeneity within tumours and speedy recovery of animals from anaesthesia so that longitudinal studies (e.g., during tumour growth or following treatment) may be conducted frequently.


  • Open Access

    Maternal and fetal cardiometabolic recovery following ultrasound-guided high-intensity focused ultrasound placental vascular occlusion

    by Caroline J. Shaw, Ian Rivens, John Civale, Kimberley J. Botting, Beth J. Allison, Kirsty L. Brain, Y. Niu, Gail ter Haar, Dino A. Giussani, Christoph C. Lees

    High-intensity focused ultrasound (HIFU) is a non-invasive method of selective placental vascular occlusion, providing a potential therapy for conditions such as twin–twin transfusion syndrome. In order to translate this technique into human studies, evidence of prolonged fetal recovery and maintenance of a healthy fetal physiology following exposure to HIFU is essential. At 116 ± 2 days gestation, 12 pregnant ewes were assigned to control ( n = 6) or HIFU vascular occlusion ( n = 6) groups and anaesthetized. Placental blood vessels were identified using colour Doppler ultrasound; HIFU-mediated vascular occlusion was performed through intact maternal skin (1.66 MHz, 5 s duration, in situ I SPTA 1.8–3.9 kW cm −2 ). Unidentifiable colour Doppler signals in targeted vessels following HIFU exposure denoted successful occlusion. Ewes and fetuses were then surgically instrumented with vascular catheters and transonic flow probes and recovered from anaesthesia. A custom-made wireless data acquisition system, which records continuous maternal and fetal cardiovascular data, and daily blood sampling were used to assess wellbeing for 20 days, followed by post-mortem examination. Based on a comparison of pre- and post-treatment colour Doppler imaging, 100% (36/36) of placental vessels were occluded following HIFU, and occlusion persisted for 20 days. All fetuses survived. No differences in maternal or fetal blood pressure, heart rate, heart rate variability, metabolic status or oxygenation were observed between treatment groups. There was evidence of normal fetal maturation and no evidence of chronic fetal stress. There were no maternal injuries and no placental vascular haemorrhage. There was both a uterine and fetal burn, which did not result in any obstetric or fetal complications. This study demonstrates normal long-term recovery of fetal sheep from exposure to HIFU-mediated placental vascular occlusion and underlines the potential of HIFU as a potential non-invasive therapy in human pregnancy.


  • Open Access

    Focused ultrasound transducer spatial peak intensity estimation: a comparison of methods

    by John Civale, Ian Rivens, Adam Shaw, Gail ter Haar

    Characterisation of the spatial peak intensity at the focus of high intensity focused ultrasound transducers is difficult because of the risk of damage to hydrophone sensors at the high focal pressures generated. Hill et al (1994 Ultrasound Med. Biol. 20 259-69) provided a simple equation for estimating spatial-peak intensity for solid spherical bowl transducers using measured acoustic power and focal beamwidth. This paper demonstrates theoretically and experimentally that this expression is only strictly valid for spherical bowl transducers without a central (imaging) aperture. A hole in the centre of the transducer results in over-estimation of the peak intensity. Improved strategies for determining focal peak intensity from a measurement of total acoustic power are proposed. Four methods are compared: (i) a solid spherical bowl approximation (after Hill et al 1994 Ultrasound Med. Biol. 20 259-69), (ii) a numerical method derived from theory, (iii) a method using measured sidelobe to focal peak pressure ratio, and (iv) a method for measuring the focal power fraction (FPF) experimentally. Spatial-peak intensities were estimated for 8 transducers at three drive powers levels: low (approximately 1 W), moderate (~10 W) and high (20-70 W). The calculated intensities were compared with those derived from focal peak pressure measurements made using a calibrated hydrophone. The FPF measurement method was found to provide focal peak intensity estimates that agreed most closely (within 15%) with the hydrophone measurements, followed by the pressure ratio method (within 20%). The numerical method was found to consistently over-estimate focal peak intensity (+40% on average), however, for transducers with a central hole it was more accurate than using the solid bowl assumption (+70% over-estimation). In conclusion, the ability to make use of an automated beam plotting system, and a hydrophone with good spatial resolution, greatly facilitates characterisation of the FPF, and consequently gives improved confidence in estimating spatial peak intensity from measurement of acoustic power.


  • The role of cavitation in vascular occlusion

    by Gail ter Haar, Ian Rivens, John Civale, Caroline Shaw, Dino Giussani, Christoph Lees

    Ed Carstensen’s papers on the effects of ultrasound on plants were amongst the first that attracted me to study ultrasound bio-effects. It was little surprise to me that, when I first started looking at HIFU, his name was on many of the seminal papers in this area. And now, his papers on cavitation and vasculature inform our current research. Ed’s influence on bio-effects research stretches far beyond the borders of the USA Vascular occlusion has the potential to treat life-threatening conditions including twin-twin transfusion syndrome (occurring in fetuses that share a placenta). Sheep placental vessels have been used to develop HIFU treatment guidance, delivery (1.66MHz) and monitoring. Ultrasound imaging guidance/flow monitoring, with simultaneous acoustic cavitation detection in 82 targets in 14 pregnant sheep resulted in flow occlusion in 90%. Adverse events included skin erythema (18/82) and burns (10/82), but all resolved over 21 days. Analysis of acoustic cavitation required low pass (software) filtering and careful choice of broadband integration range (0.1 to 1.1 MHz). 9% of successful treatments displayed detectable broadband, 32% with half-harmonic and 1% with drive-voltage fluctuations. In conclusion, treatment is possible, side effects are manageable, and acoustic cavitation appears not to be essential for successful occlusion.

  • Cavitation threshold determination —Can we do it?

    by Gail ter Haar, John Civale, Ian Rivens, Marcia Costa